Accessed via an easy-to-use, intuitive user interface, Pharmaview provides objective, invaluable analysis and insight into the biopharmaceutical industry.
Company Analysis
Updated on an ongoing basis with the latest news and analysis, our Company Analysis provides independent and objective insight into the strategy and business development activities, among the 50 leading pharmaceutical and biotechnology companies. This includes:
- Corporate, geographic, therapeutic and business development strategies
- Coverage of major strategic moves and product/technology deals
- Details of leading marketed products and franchises including historic sales data and independent 7-year forecasts by company
- Coverage of key R&D candidates and pipelines
- Insight into factors affecting the future prospects for specific products and R&D candidates
- Updated monthly, our industry-leading experts track and analyze major company events, helping you to keep on top of key issues
Therapy Analysis
With all relevant information grouped by therapy area, our Therapy Analysis provides access to disease area overviews, therapy area rankings by company and licensing deal overviews. In addition, product portfolios and sales forecasts can be viewed by individual therapeutic class and by individual companies participating in a specific therapy area. This includes:
- Transparent forecasts and assumptions for more than 1,000 products, in 147 product classes, across 14 therapy areas, providing insight into which therapies are predicted to drive future growth in the pharmaceutical industry
- Analysis of the current state of key therapeutic areas, together with the likely strategic development plans for each participating company
- User-customizable Excel forecasting models enabling drug forecasts and data charting ability
- Updated monthly, our industry-leading experts track and analyze major therapy area events, helping you to keep on top of key issues
Industry Analysis
Providing up-to-date analysis and insight into the industry-wide and territory-specific issues shaping the pharmaceutical industry, our Industry Analysis helps busy executives cut through the news flow and understand the impact of key events. This includes:
- Concise and comparable analysis, together with key reference data and ready-to-use graphics, focusing on the healthcare/pharmaceutical business environment in the G7 and emerging markets
- Monthly event reports covering key industry developments and their potential impact on the global pharmaceutical and biotechnology markets
- Background reports provide summaries of the structure and key features of each country’s healthcare and pharmaceutical market
- Industry rankings of companies, products and therapy areas
- Thought leadership from a team of career experienced analysts and consultants—delivering intelligent and objective viewpoints on the issues that matter
Industry analysis also provides access to our invaluable
Executive's Guide.